Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Int J Pediatr Otorhinolaryngol ; 74(3): 326-7, 2010 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-20060599

RESUMO

Secondary tracheo-oesophageal fistula in delayed primary repair of oesophageal atresia is rare. This paper reports the successful use of the KTP laser in the treatment of this condition in a refractory case. It also recommends the use of direct laryngotracheobronchoscopy (DLTB) in the diagnosis. We recommend the use of this laser in cases of recurrent tracheo-esophageal fistula especially when other means have failed.


Assuntos
Atresia Esofágica/cirurgia , Lasers de Estado Sólido/uso terapêutico , Pneumonia/complicações , Fístula Traqueoesofágica/complicações , Fístula Traqueoesofágica/cirurgia , Broncoscopia , Atresia Esofágica/complicações , Gastrostomia , Humanos , Recém-Nascido , Laringoscopia , Masculino , Pneumonia/diagnóstico
2.
Paediatr Anaesth ; 16(4): 417-23, 2006 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-16618296

RESUMO

BACKGROUND: The aim of our study was to measure the serum paracetamol concentrations achieved following a single rectal loading dose of 40 mg x kg(-1) in children with chronic liver disease. METHODS: We recruited 17 children (3-15 years, 10.6-75 kg) undergoing minor surgical procedures under general anesthesia. Paracetamol was administered at the end of surgery and blood samples were taken for analysis at 2, 3, 4, 6 and 8 h postdose. RESULTS: The mean Cmax of 11.4 mg x l(-1) [coefficient of variation (CV) 66%] was achieved at a Tmax of 2.7 h (CV 42%). The relative bioavailability (F) of the suppository formulation was not estimated, but clearance (Cl/F) estimates 0.73 l x kg(-1) x h(-1) (CV 87%) and time-concentration profiles for these children were similar to the normal pediatric population. CONCLUSIONS: There are currently no biologic markers available for monitoring possible hepatotoxicity in this cohort of patients with liver disease, but our data suggest that a single-dose suppository is a satisfactory analgesic alternative.


Assuntos
Acetaminofen/administração & dosagem , Acetaminofen/farmacocinética , Analgésicos não Narcóticos/administração & dosagem , Analgésicos não Narcóticos/farmacocinética , Hepatopatias/metabolismo , Acetaminofen/sangue , Administração Retal , Adolescente , Analgésicos não Narcóticos/sangue , Anestesia Geral , Disponibilidade Biológica , Criança , Pré-Escolar , Doença Crônica , Feminino , Humanos , Coeficiente Internacional Normatizado , Testes de Função Hepática , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA